Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Katayama

Showing results (411-420 of 491) with videos related to

Pageof 50
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1984
[Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram]H Okazaki, T Hasegawa, T Fujimori, et al.
Life Sciences|August 18, 2000
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cellsI Inoue, S Goto, K Mizotani, et al.
Annals of Clinical Biochemistry|March 29, 2000
Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cellsT Nakajima, N Origuchi, T Matsunaga, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1991
Effect of dietary calcium on renal prostaglandinsS Katayama, Y Maruno, A Itabashi, et al.
Nihon Naibunpi Gakkai Zasshi|March 20, 1987
[Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease]K Miki, J Takamatsu, S Sakane, et al.
Clinical Endocrinology|August 26, 1998
Serum substances that interfere with thyroid hormone assays in patients with chronic renal failureM Iitaka, S Kawasaki, S Sakurai, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 1, 1986
[General pharmacological action of tritoqualine (TRQ; (+/-)-(R*)-7-amino-4, 5, 6-triethoxy-3-[(R*)-5, 6, 7, 8-tetrahydro-4-methoxy-6-methyl-1, 3-dioxolo [4, 5-g] isoquinolin-5-yl] phthalide]A Narimatsu, K Nakao, M Egawa, et al.
Journal of Pharmaceutical Sciences|October 7, 2021
Analysis of Peptides using Asymmetrical Flow Field-flow Fractionation (AF4)Ryan R Manning, Ryan E Holcomb, Derrick S Katayama, et al.
Current Protein & Peptide Science|November 4, 2022
Characterization of Oligomer Formation of Surfactant Protein-D (SP-D) Using AF4-MALLSRyan R Manning, Ryan E Holcomb, Derrick S Katayama, et al.
Oncotarget|October 5, 2020
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?Erryk S Katayama, Jonathan J Hue, David L Bajor, et al.
Pageof 50

Showing results (411-420 of 491) with videos related to

Sort By:
Pageof 50
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1984
[Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram]H Okazaki, T Hasegawa, T Fujimori, et al.
Life Sciences|August 18, 2000
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cellsI Inoue, S Goto, K Mizotani, et al.
Annals of Clinical Biochemistry|March 29, 2000
Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cellsT Nakajima, N Origuchi, T Matsunaga, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1991
Effect of dietary calcium on renal prostaglandinsS Katayama, Y Maruno, A Itabashi, et al.
Nihon Naibunpi Gakkai Zasshi|March 20, 1987
[Pathological characteristics of the thyroid gland in patients with triiodothyronine-predominant Graves' disease]K Miki, J Takamatsu, S Sakane, et al.
Clinical Endocrinology|August 26, 1998
Serum substances that interfere with thyroid hormone assays in patients with chronic renal failureM Iitaka, S Kawasaki, S Sakurai, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 1, 1986
[General pharmacological action of tritoqualine (TRQ; (+/-)-(R*)-7-amino-4, 5, 6-triethoxy-3-[(R*)-5, 6, 7, 8-tetrahydro-4-methoxy-6-methyl-1, 3-dioxolo [4, 5-g] isoquinolin-5-yl] phthalide]A Narimatsu, K Nakao, M Egawa, et al.
Journal of Pharmaceutical Sciences|October 7, 2021
Analysis of Peptides using Asymmetrical Flow Field-flow Fractionation (AF4)Ryan R Manning, Ryan E Holcomb, Derrick S Katayama, et al.
Current Protein & Peptide Science|November 4, 2022
Characterization of Oligomer Formation of Surfactant Protein-D (SP-D) Using AF4-MALLSRyan R Manning, Ryan E Holcomb, Derrick S Katayama, et al.
Oncotarget|October 5, 2020
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?Erryk S Katayama, Jonathan J Hue, David L Bajor, et al.
Pageof 50